nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Embolism arterial—Doxorubicin—muscle cancer	0.0747	0.0749	CcSEcCtD
Nafarelin—Prolonged menses—Vincristine—muscle cancer	0.0611	0.0612	CcSEcCtD
Nafarelin—Ascites—Dactinomycin—muscle cancer	0.0316	0.0316	CcSEcCtD
Nafarelin—Mucous membrane disorder—Doxorubicin—muscle cancer	0.0268	0.0269	CcSEcCtD
Nafarelin—Pulmonary fibrosis—Etoposide—muscle cancer	0.0236	0.0236	CcSEcCtD
Nafarelin—Ascites—Etoposide—muscle cancer	0.0228	0.0229	CcSEcCtD
Nafarelin—Interstitial pneumonia—Etoposide—muscle cancer	0.0215	0.0215	CcSEcCtD
Nafarelin—Menorrhagia—Vincristine—muscle cancer	0.0173	0.0173	CcSEcCtD
Nafarelin—Interstitial lung disease—Etoposide—muscle cancer	0.0147	0.0147	CcSEcCtD
Nafarelin—Pulmonary fibrosis—Methotrexate—muscle cancer	0.0141	0.0142	CcSEcCtD
Nafarelin—Loss of libido—Methotrexate—muscle cancer	0.0135	0.0135	CcSEcCtD
Nafarelin—Interstitial pneumonia—Methotrexate—muscle cancer	0.0129	0.0129	CcSEcCtD
Nafarelin—Ascites—Doxorubicin—muscle cancer	0.0118	0.0119	CcSEcCtD
Nafarelin—Deep vein thrombosis—Methotrexate—muscle cancer	0.0102	0.0102	CcSEcCtD
Nafarelin—Vaginal discharge—Methotrexate—muscle cancer	0.0102	0.0102	CcSEcCtD
Nafarelin—Rash maculo-papular—Etoposide—muscle cancer	0.00943	0.00945	CcSEcCtD
Nafarelin—Vaginal discharge—Doxorubicin—muscle cancer	0.00885	0.00886	CcSEcCtD
Nafarelin—Interstitial lung disease—Methotrexate—muscle cancer	0.00878	0.0088	CcSEcCtD
Nafarelin—Myasthenia—Doxorubicin—muscle cancer	0.00856	0.00858	CcSEcCtD
Nafarelin—Muscular weakness—Vincristine—muscle cancer	0.0082	0.00821	CcSEcCtD
Nafarelin—Pleural effusion—Methotrexate—muscle cancer	0.00812	0.00813	CcSEcCtD
Nafarelin—Seborrhoeic dermatitis—Doxorubicin—muscle cancer	0.0079	0.00791	CcSEcCtD
Nafarelin—Dysuria—Vincristine—muscle cancer	0.00752	0.00753	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Doxorubicin—muscle cancer	0.00727	0.00728	CcSEcCtD
Nafarelin—Weight decreased—Vincristine—muscle cancer	0.00727	0.00728	CcSEcCtD
Nafarelin—Depression—Vincristine—muscle cancer	0.00715	0.00716	CcSEcCtD
Nafarelin—Acute coronary syndrome—Vincristine—muscle cancer	0.00707	0.00708	CcSEcCtD
Nafarelin—Pleural effusion—Doxorubicin—muscle cancer	0.00703	0.00704	CcSEcCtD
Nafarelin—Myocardial infarction—Vincristine—muscle cancer	0.00703	0.00704	CcSEcCtD
Nafarelin—Oliguria—Methotrexate—muscle cancer	0.00675	0.00676	CcSEcCtD
Nafarelin—Herpes simplex—Methotrexate—muscle cancer	0.00675	0.00676	CcSEcCtD
Nafarelin—Liver injury—Doxorubicin—muscle cancer	0.0064	0.00641	CcSEcCtD
Nafarelin—Alopecia—Dactinomycin—muscle cancer	0.00636	0.00637	CcSEcCtD
Nafarelin—Sweating increased—Etoposide—muscle cancer	0.00634	0.00635	CcSEcCtD
Nafarelin—Pulmonary embolism—Methotrexate—muscle cancer	0.00622	0.00623	CcSEcCtD
Nafarelin—Breast pain—Doxorubicin—muscle cancer	0.00617	0.00618	CcSEcCtD
Nafarelin—Cystitis noninfective—Methotrexate—muscle cancer	0.00607	0.00608	CcSEcCtD
Nafarelin—Cystitis—Methotrexate—muscle cancer	0.006	0.00601	CcSEcCtD
Nafarelin—Herpes simplex—Doxorubicin—muscle cancer	0.00584	0.00585	CcSEcCtD
Nafarelin—Oliguria—Doxorubicin—muscle cancer	0.00584	0.00585	CcSEcCtD
Nafarelin—Acute coronary syndrome—Etoposide—muscle cancer	0.00572	0.00573	CcSEcCtD
Nafarelin—Myocardial infarction—Etoposide—muscle cancer	0.00569	0.0057	CcSEcCtD
Nafarelin—Alopecia—Vincristine—muscle cancer	0.00569	0.00569	CcSEcCtD
Nafarelin—Mental disorder—Vincristine—muscle cancer	0.00564	0.00565	CcSEcCtD
Nafarelin—Bladder pain—Methotrexate—muscle cancer	0.00562	0.00563	CcSEcCtD
Nafarelin—Neoplasm—Methotrexate—muscle cancer	0.00562	0.00563	CcSEcCtD
Nafarelin—Gynaecomastia—Methotrexate—muscle cancer	0.00556	0.00557	CcSEcCtD
Nafarelin—Coordination abnormal—Doxorubicin—muscle cancer	0.00548	0.00549	CcSEcCtD
Nafarelin—Pulmonary embolism—Doxorubicin—muscle cancer	0.00538	0.00539	CcSEcCtD
Nafarelin—Myalgia—Dactinomycin—muscle cancer	0.00534	0.00534	CcSEcCtD
Nafarelin—Cystitis noninfective—Doxorubicin—muscle cancer	0.00526	0.00527	CcSEcCtD
Nafarelin—Cystitis—Doxorubicin—muscle cancer	0.0052	0.00521	CcSEcCtD
Nafarelin—Oedema—Dactinomycin—muscle cancer	0.00512	0.00512	CcSEcCtD
Nafarelin—Vertigo—Vincristine—muscle cancer	0.00503	0.00504	CcSEcCtD
Nafarelin—Rash maculo-papular—Doxorubicin—muscle cancer	0.00489	0.0049	CcSEcCtD
Nafarelin—Anorexia—Dactinomycin—muscle cancer	0.00488	0.00488	CcSEcCtD
Nafarelin—Bladder pain—Doxorubicin—muscle cancer	0.00487	0.00487	CcSEcCtD
Nafarelin—Neoplasm—Doxorubicin—muscle cancer	0.00487	0.00487	CcSEcCtD
Nafarelin—Convulsion—Vincristine—muscle cancer	0.00485	0.00486	CcSEcCtD
Nafarelin—Myalgia—Vincristine—muscle cancer	0.00477	0.00478	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00466	0.00467	CcSEcCtD
Nafarelin—Alopecia—Etoposide—muscle cancer	0.00461	0.00461	CcSEcCtD
Nafarelin—Cerebrovascular accident—Methotrexate—muscle cancer	0.00461	0.00461	CcSEcCtD
Nafarelin—Oedema—Vincristine—muscle cancer	0.00457	0.00458	CcSEcCtD
Nafarelin—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00447	0.00448	CcSEcCtD
Nafarelin—Decreased appetite—Dactinomycin—muscle cancer	0.00445	0.00445	CcSEcCtD
Nafarelin—Dysgeusia—Etoposide—muscle cancer	0.00444	0.00445	CcSEcCtD
Nafarelin—Hyperhidrosis—Vincristine—muscle cancer	0.00442	0.00443	CcSEcCtD
Nafarelin—Anorexia—Vincristine—muscle cancer	0.00436	0.00436	CcSEcCtD
Nafarelin—Eye pain—Doxorubicin—muscle cancer	0.00433	0.00433	CcSEcCtD
Nafarelin—Mood swings—Methotrexate—muscle cancer	0.00428	0.00428	CcSEcCtD
Nafarelin—Hot flush—Doxorubicin—muscle cancer	0.00418	0.00418	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00416	0.00417	CcSEcCtD
Nafarelin—Increased appetite—Doxorubicin—muscle cancer	0.00416	0.00417	CcSEcCtD
Nafarelin—Menopausal symptoms—Doxorubicin—muscle cancer	0.00414	0.00415	CcSEcCtD
Nafarelin—Insomnia—Vincristine—muscle cancer	0.00413	0.00414	CcSEcCtD
Nafarelin—Paraesthesia—Vincristine—muscle cancer	0.0041	0.00411	CcSEcCtD
Nafarelin—Vertigo—Etoposide—muscle cancer	0.00408	0.00408	CcSEcCtD
Nafarelin—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00399	0.00399	CcSEcCtD
Nafarelin—Decreased appetite—Vincristine—muscle cancer	0.00397	0.00398	CcSEcCtD
Nafarelin—Convulsion—Etoposide—muscle cancer	0.00393	0.00394	CcSEcCtD
Nafarelin—Constipation—Vincristine—muscle cancer	0.00391	0.00391	CcSEcCtD
Nafarelin—Chest pain—Etoposide—muscle cancer	0.00386	0.00387	CcSEcCtD
Nafarelin—Affect lability—Doxorubicin—muscle cancer	0.00385	0.00385	CcSEcCtD
Nafarelin—Mood swings—Doxorubicin—muscle cancer	0.0037	0.00371	CcSEcCtD
Nafarelin—Asthenia—Dactinomycin—muscle cancer	0.00367	0.00368	CcSEcCtD
Nafarelin—Dysuria—Methotrexate—muscle cancer	0.00365	0.00365	CcSEcCtD
Nafarelin—Dry skin—Doxorubicin—muscle cancer	0.00358	0.00359	CcSEcCtD
Nafarelin—Hyperhidrosis—Etoposide—muscle cancer	0.00358	0.00358	CcSEcCtD
Nafarelin—Anorexia—Etoposide—muscle cancer	0.00353	0.00353	CcSEcCtD
Nafarelin—Diarrhoea—Dactinomycin—muscle cancer	0.0035	0.00351	CcSEcCtD
Nafarelin—Depression—Methotrexate—muscle cancer	0.00347	0.00347	CcSEcCtD
Nafarelin—Gastritis—Doxorubicin—muscle cancer	0.00346	0.00346	CcSEcCtD
Nafarelin—Muscular weakness—Doxorubicin—muscle cancer	0.00345	0.00345	CcSEcCtD
Nafarelin—Abdominal distension—Doxorubicin—muscle cancer	0.0034	0.00341	CcSEcCtD
Nafarelin—Conjunctivitis—Methotrexate—muscle cancer	0.00338	0.00339	CcSEcCtD
Nafarelin—Paraesthesia—Etoposide—muscle cancer	0.00333	0.00333	CcSEcCtD
Nafarelin—Dyspnoea—Etoposide—muscle cancer	0.0033	0.00331	CcSEcCtD
Nafarelin—Epistaxis—Methotrexate—muscle cancer	0.00328	0.00329	CcSEcCtD
Nafarelin—Asthenia—Vincristine—muscle cancer	0.00328	0.00328	CcSEcCtD
Nafarelin—Vomiting—Dactinomycin—muscle cancer	0.00325	0.00326	CcSEcCtD
Nafarelin—Rash—Dactinomycin—muscle cancer	0.00323	0.00323	CcSEcCtD
Nafarelin—Decreased appetite—Etoposide—muscle cancer	0.00322	0.00322	CcSEcCtD
Nafarelin—Constipation—Etoposide—muscle cancer	0.00317	0.00317	CcSEcCtD
Nafarelin—Dysuria—Doxorubicin—muscle cancer	0.00316	0.00316	CcSEcCtD
Nafarelin—Diarrhoea—Vincristine—muscle cancer	0.00313	0.00313	CcSEcCtD
Nafarelin—Weight increased—Doxorubicin—muscle cancer	0.00307	0.00308	CcSEcCtD
Nafarelin—Weight decreased—Doxorubicin—muscle cancer	0.00306	0.00306	CcSEcCtD
Nafarelin—Nausea—Dactinomycin—muscle cancer	0.00304	0.00304	CcSEcCtD
Nafarelin—Dizziness—Vincristine—muscle cancer	0.00302	0.00303	CcSEcCtD
Nafarelin—Urticaria—Etoposide—muscle cancer	0.00294	0.00295	CcSEcCtD
Nafarelin—Conjunctivitis—Doxorubicin—muscle cancer	0.00293	0.00293	CcSEcCtD
Nafarelin—Vomiting—Vincristine—muscle cancer	0.00291	0.00291	CcSEcCtD
Nafarelin—Rash—Vincristine—muscle cancer	0.00288	0.00289	CcSEcCtD
Nafarelin—Dermatitis—Vincristine—muscle cancer	0.00288	0.00288	CcSEcCtD
Nafarelin—Headache—Vincristine—muscle cancer	0.00286	0.00287	CcSEcCtD
Nafarelin—Epistaxis—Doxorubicin—muscle cancer	0.00284	0.00284	CcSEcCtD
Nafarelin—Sinusitis—Doxorubicin—muscle cancer	0.00283	0.00283	CcSEcCtD
Nafarelin—Alopecia—Methotrexate—muscle cancer	0.00276	0.00276	CcSEcCtD
Nafarelin—Mental disorder—Methotrexate—muscle cancer	0.00274	0.00274	CcSEcCtD
Nafarelin—Malnutrition—Methotrexate—muscle cancer	0.00272	0.00272	CcSEcCtD
Nafarelin—Nausea—Vincristine—muscle cancer	0.00272	0.00272	CcSEcCtD
Nafarelin—Rhinitis—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Nafarelin—Dysgeusia—Methotrexate—muscle cancer	0.00266	0.00267	CcSEcCtD
Nafarelin—Asthenia—Etoposide—muscle cancer	0.00266	0.00266	CcSEcCtD
Nafarelin—Pruritus—Etoposide—muscle cancer	0.00262	0.00262	CcSEcCtD
Nafarelin—Diarrhoea—Etoposide—muscle cancer	0.00253	0.00254	CcSEcCtD
Nafarelin—Dizziness—Etoposide—muscle cancer	0.00245	0.00245	CcSEcCtD
Nafarelin—Vertigo—Methotrexate—muscle cancer	0.00244	0.00245	CcSEcCtD
Nafarelin—Alopecia—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Nafarelin—Mental disorder—Doxorubicin—muscle cancer	0.00237	0.00237	CcSEcCtD
Nafarelin—Convulsion—Methotrexate—muscle cancer	0.00235	0.00236	CcSEcCtD
Nafarelin—Vomiting—Etoposide—muscle cancer	0.00235	0.00236	CcSEcCtD
Nafarelin—Malnutrition—Doxorubicin—muscle cancer	0.00235	0.00236	CcSEcCtD
Nafarelin—Rash—Etoposide—muscle cancer	0.00233	0.00234	CcSEcCtD
Nafarelin—Dermatitis—Etoposide—muscle cancer	0.00233	0.00234	CcSEcCtD
Nafarelin—Headache—Etoposide—muscle cancer	0.00232	0.00232	CcSEcCtD
Nafarelin—Myalgia—Methotrexate—muscle cancer	0.00231	0.00232	CcSEcCtD
Nafarelin—Arthralgia—Methotrexate—muscle cancer	0.00231	0.00232	CcSEcCtD
Nafarelin—Chest pain—Methotrexate—muscle cancer	0.00231	0.00232	CcSEcCtD
Nafarelin—Tension—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Nafarelin—Dysgeusia—Doxorubicin—muscle cancer	0.0023	0.00231	CcSEcCtD
Nafarelin—Nervousness—Doxorubicin—muscle cancer	0.00229	0.00229	CcSEcCtD
Nafarelin—Nausea—Etoposide—muscle cancer	0.0022	0.0022	CcSEcCtD
Nafarelin—Hyperhidrosis—Methotrexate—muscle cancer	0.00214	0.00215	CcSEcCtD
Nafarelin—Vertigo—Doxorubicin—muscle cancer	0.00211	0.00212	CcSEcCtD
Nafarelin—Anorexia—Methotrexate—muscle cancer	0.00211	0.00212	CcSEcCtD
Nafarelin—Palpitations—Doxorubicin—muscle cancer	0.00208	0.00208	CcSEcCtD
Nafarelin—Convulsion—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00202	0.00202	CcSEcCtD
Nafarelin—Insomnia—Methotrexate—muscle cancer	0.00201	0.00201	CcSEcCtD
Nafarelin—Chest pain—Doxorubicin—muscle cancer	0.002	0.00201	CcSEcCtD
Nafarelin—Myalgia—Doxorubicin—muscle cancer	0.002	0.00201	CcSEcCtD
Nafarelin—Arthralgia—Doxorubicin—muscle cancer	0.002	0.00201	CcSEcCtD
Nafarelin—Paraesthesia—Methotrexate—muscle cancer	0.00199	0.00199	CcSEcCtD
Nafarelin—Dyspnoea—Methotrexate—muscle cancer	0.00198	0.00198	CcSEcCtD
Nafarelin—Decreased appetite—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Nafarelin—Oedema—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Nafarelin—Shock—Doxorubicin—muscle cancer	0.00189	0.00189	CcSEcCtD
Nafarelin—Hyperhidrosis—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Nafarelin—Anorexia—Doxorubicin—muscle cancer	0.00183	0.00183	CcSEcCtD
Nafarelin—Urticaria—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00175	0.00175	CcSEcCtD
Nafarelin—Insomnia—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Nafarelin—Paraesthesia—Doxorubicin—muscle cancer	0.00172	0.00173	CcSEcCtD
Nafarelin—Dyspnoea—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Nafarelin—Decreased appetite—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Nafarelin—Constipation—Doxorubicin—muscle cancer	0.00164	0.00164	CcSEcCtD
Nafarelin—Asthenia—Methotrexate—muscle cancer	0.00159	0.00159	CcSEcCtD
Nafarelin—Pruritus—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Nafarelin—Urticaria—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Nafarelin—Diarrhoea—Methotrexate—muscle cancer	0.00152	0.00152	CcSEcCtD
Nafarelin—Desmopressin—PTGS2—muscle cancer	0.00148	1	CrCbGaD
Nafarelin—Dizziness—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Nafarelin—Vomiting—Methotrexate—muscle cancer	0.00141	0.00141	CcSEcCtD
Nafarelin—Rash—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Nafarelin—Dermatitis—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Nafarelin—Headache—Methotrexate—muscle cancer	0.00139	0.00139	CcSEcCtD
Nafarelin—Asthenia—Doxorubicin—muscle cancer	0.00138	0.00138	CcSEcCtD
Nafarelin—Pruritus—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Nafarelin—Nausea—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Nafarelin—Diarrhoea—Doxorubicin—muscle cancer	0.00131	0.00132	CcSEcCtD
Nafarelin—Dizziness—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Nafarelin—Vomiting—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Nafarelin—Rash—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Dermatitis—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Nafarelin—Headache—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Nafarelin—Nausea—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
